HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Plerixafor-d4

HCID 71751717
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1246819-87-3
Standard SMILES
[2H]c1c([2H])c(CN2CCCNCCNCCCNCC2)c([2H])c([2H])c1CN1CCCNCCNCCCNCC1
InChIKey
YIQPUIGJQJDJOS-KDWZCNHSSA-N
Molecular formula
C28H54N8
Average molar mass
506.8 g/mol
Monoisotopic mass
506.47225074

Names & identifiers

Preferred name
Plerixafor-d4
IUPAC
1-[[2,3,5,6-tetradeuterio-4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane
English name
Plerixafor
Molecular formula
C28H54N8
Molecular weight
502.78196

Names & synonyms

Plerixafor-d41246819-87-31-[[2,3,5,6-tetradeuterio-4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecanePlerixafor-dC28H54N81,1'-[1,4-(Phenylene-d4)bis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane;orb3138430TMID-0641DTXSID00858326HY-10046SMFCD19705148CS-0203112
Show more names
[2H4]-PlerixaforPaclobutrazol Impurity 6
1,1'-[(~2~H_4_)-1,4-Phenylenebis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane)

Database identifiers

CAS
1246819-87-3
PubChem CID
71751717
DTXSID
DTXSID00858326

Properties

Computed structural propertiesFilling in

XLogP
0
Topological polar surface area
78.7 Ų
Hydrogen bond donors
6
Hydrogen bond acceptors
8
Rotatable bonds
4
Heavy atoms
36
Formal charge
0
Complexity
456

Physicochemical properties

Melting point
100 · 100-102°C
storage temp.
Hygroscopic, Refrigerator, Under Inert Atmosphere
solubility
DMSO (Slightly, Heated, Sonicated), Methanol (Slightly), Water (Slightly)
form
Solid
color
White to Light Yellow
Stability
Very Hygroscopic

Chemistry & industry

Applications · 2 items

DescriptionPlerixafor-d4 is intended for use as an internal standard for the quantification of plerixafor by GC- or LC-MS. Plerixafor is a partial antagonist of chemokine receptor 4 (CXCR4) with IC50 values ranging from 0.02 to 0.13 μg/ml for inhibiting calcium flux in peripheral blood mononuclear cells (PBMCs), various types of T cells, and mouse lymphocytic leukemia cells. It is selective for CXCR4 over CXCR1-3 and CXCR5-9 (IC50s = >25 μg/ml). Plerixafor decreases infectious virus content in the supernatant of Jurkat cells chronically infected with HIV-1(IIIB) (EC50 = ~0.02 μg/ml). It rapidly mobilizes murine and human hematopoietic stem and murine long-term repopulating cells for transplantation alone and, with a synergistic effect, when used in combination with G-CSF. Plerixafor also increases T cell trafficking in mouse blood, spleen, and central nervous system. Plerixafor (1.25 mg/kg twice per day) decreases the number of 4T1 murine mammary carcinoma cells in the lung in a mouse model of lung metastasis.

UsesLabelled Plerixafor, it is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-α (SDF-1-α). This agent was approved on Dec. 15, 2008, as treatment in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize HSCs to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin''s lymphoma (NHL) and multiple myeloma (MM).

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes